Kevin J. Black try to fix Denys and Catalyst Pharm refs  almost 8 years ago

Commit id: 4dd163c2f468ce6808267ebf95a463f6c721eca4

deletions | additions      

       

@misc{vigabatrinPR,  author = {{Catalyst Pharmaceutical Partners, Inc.},}, {Catalyst {P}harmaceutical {P}artners, {I}nc.,}de,  title = {Catalyst {P}harmaceuticals Announces Encouraging Top-Line Results in Proof-of-Concept Trial of Vigabatrin in Patients With Treatment-Refractory {T}ourette's {D}isorder},  year = {2015},  howpublished = {\url{http://ir.catalystpharma.com/releasedetail.cfm?ReleaseID=919254}, archived by WebCite® at http://www.webcitation.org/6hNRye6tt}, 

@article{23876376,  title = {{Dopaminergic {Dopaminergic  activity in Tourette {T}ourette  syndrome and obsessive-compulsive disorder.}}, disorder},  date = {2013 Nov},  source = {Eur Neuropsychopharmacol},  authors = {Denys, D and de, Vries {de Vries},  F and Cath, D and Figee, M and Vulink, N and Veltman, DJ and van, {van  der Doef Doef},  TF and Boellaard, R and Westenberg, H and van, Balkom {van Balkom},  A and Lammertsma, AA and van, Berckel {van Berckel},  BN}, author = {Denys, D and de, Vries {de Vries},  F and Cath, D and Figee, M and Vulink, N and Veltman, DJ and van, {van  der Doef Doef},  TF and Boellaard, R and Westenberg, H and van, Balkom {van Balkom},  A and Lammertsma, AA and van, Berckel {van Berckel},  BN}, year = {2013},  month = {Nov},  journal = {Eur Neuropsychopharmacol},